Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic

被引:0
|
作者
Schellhase, Ellen [1 ]
Stanko, Madeline [1 ]
Kinstler, Natalie [1 ]
Miller, Monica L. [1 ]
Antoniou, Sotiris [2 ]
Fhadil, Sadeer [2 ]
Patel, Mital [2 ]
Wright, Paul [2 ]
机构
[1] Purdue Univ Coll Pharm, W Lafayette, IN 47907 USA
[2] St Bartholomews Hosp, London EC1A 7BE, England
关键词
anticoagulation; atrial fibrillation; cardiac implantable electronic devices; cardiac pharmacists; medication optimization; direct oral anticoagulants; non-vitamin k oral anticoagulants; cardiovascular optimization; STROKE; ANTICOAGULATION; THERAPY; ORBIT; RISK;
D O I
10.3390/pharmacy11020048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For patients with cardiac implantable electronic devices (CIEDs), arrythmias such as atrial fibrillation (AF) can be detected and actions taken to rapidly assess and initiate treatment where appropriate. Actions include timely initiation of anticoagulation, review of blood pressure, and optimization of cholesterol/lipids to prevent unfavorable outcomes, such as stroke and other cardiovascular complications. Delays to initiating anticoagulation can have devastating consequences. We sought to implement a virtual clinic, where a pharmacist reviews patient referrals from a CIED clinic after detecting AF from the CIED. Anticoagulation choice is determined by patient-specific factors, and a shared patient-provider decision to start oral anticoagulation is made. In addition, blood pressure readings and medications are assessed with lipid-lowering therapies for optimization. A total of 315 patients have been admitted through this clinic and anticoagulated over a two-year span; in addition, 322 successful interventions were made for optimization of cardiac therapy. Rapid initiation of anticoagulation within five days of referral was likely to have reduced unfavorable outcomes, such as stroke and other cardiovascular optimizations, leading to improved patient outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Erratum to: Noise from a dysfunctional atrial lead detected as atrial fibrillation by a cardiac implantable electronic device
    S. S. Barold
    F. Van Heuverswyn
    Herzschrittmachertherapie + Elektrophysiologie, 2017, 28 (1) : 63 - 63
  • [2] IMPACT OF NEW-ONSET ATRIAL FIBRILLATION DETECTED BY CARDIAC IMPLANTABLE ELECTRONIC DEVICES ON EMBOLIC STROKE EVENTS
    Nakano, Miyo
    Kondo, Yusuke
    Nakano, Masahiro
    Kajiyama, Takatsugu
    Chiba, Toshinori
    Ryuzaki, Satoko
    Kobayashi, Yoshio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1825 - 1825
  • [3] Impact of New-Onset Atrial Fibrillation Detected by Cardiac Implantable Electronic Devices on Embolic Stroke Events
    Nakano, Miyo
    Kondo, Yusuke
    Nakano, Masahiro
    Kajiyama, Takatsugu
    Ito, Ryo
    Chiba, Toshinori
    Sugawara, Masafumi
    Yoshino, Yutaka
    Ryuzaki, Satoko
    Komai, Yuya
    Takanashi, Yukiko
    Kobayashi, Yoshio
    CIRCULATION, 2023, 148
  • [4] Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices
    DeCicco, Anthony E.
    Finkel, Jonathan B.
    Greenspon, Arnold J.
    Frisch, Daniel R.
    HEART RHYTHM, 2014, 11 (04) : 719 - 724
  • [5] Prognostic impact of newly detected atrial fibrillation in patients with hypertrophic cardiomyopathy following cardiac implantable electronic device implantation
    Hayashi, Hiroshi
    Iwasaki, Yu-Ki
    Arai, Toshiki
    Mimuro, Rei
    Hachisuka, Masato
    Maru, Yujin
    Fujimoto, Yuhi
    Oka, Eiichiro
    Hagiwara, Kanako
    Imori, Yoichi
    Yamamoto, Teppei
    Murata, Hiroshige
    Yodogawa, Kenji
    Takano, Hitoshi
    Shimizu, Wataru
    HEART AND VESSELS, 2021, 36 (05) : 667 - 674
  • [6] Prognostic impact of newly detected atrial fibrillation in patients with hypertrophic cardiomyopathy following cardiac implantable electronic device implantation
    Hiroshi Hayashi
    Yu-ki Iwasaki
    Toshiki Arai
    Rei Mimuro
    Masato Hachisuka
    Yujin Maru
    Yuhi Fujimoto
    Eiichiro Oka
    Kanako Hagiwara
    Yoichi Imori
    Teppei Yamamoto
    Hiroshige Murata
    Kenji Yodogawa
    Hitoshi Takano
    Wataru Shimizu
    Heart and Vessels, 2021, 36 : 667 - 674
  • [7] Impact of stroke events in Japanese patients with atrial fibrillation detected by cardiac implantable electronic devices
    Nakano, M.
    Kondo, Y.
    Nakano, M.
    Miyazawa, K.
    Hayashi, T.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1276 - 1277
  • [8] Clinical Implication of New-Onset Atrial Fibrillation in the Individuals With Cardiac Implantable Electronic Devices
    Kataoka, Naoya
    Imamura, Teruhiko
    KOREAN CIRCULATION JOURNAL, 2024, 54 (03) : 156 - 157
  • [9] Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation
    Black-Maier, Eric
    Kim, Sunghee
    Steinberg, Benjamin A.
    Fonarow, Gregg C.
    Freeman, James V.
    Kowey, Peter R.
    Ansell, Jack
    Gersh, Bernard J.
    Mahaffey, Kenneth W.
    Naccarelli, Gerald
    Hylek, Elaine M.
    Go, Alan S.
    Peterson, Eric D.
    Piccini, Jonathan P.
    CLINICAL CARDIOLOGY, 2017, 40 (09) : 746 - 751
  • [10] Impact of Atrial Fibrillation Detected by Cardiac Implantable Electronic Devices on Embolic Stroke Events in Cancer Patients
    Nakano, Miyo
    Kondo, Yusuke
    Nakano, Masahiro
    Kajiyama, Takatsugu
    Ito, Ryo
    Chiba, Toshinori
    Sugawara, Masafumi
    Yoshino, Yutaka
    Ryuzaki, Satoko
    Komai, Yuya
    Takanashi, Yukiko
    Kobayashi, Yoshio
    CIRCULATION, 2023, 148